Fonar Corporation (FONR) is a publicly traded Healthcare sector company. As of May 21, 2026, FONR trades at $18.89 with a market cap of $118.81M and a P/E ratio of 0.00. FONR moved -0.08% today. Year to date, FONR is +2.05%; over the trailing twelve months it is +33.73%. Its 52-week range spans $12.00 to $18.95. Rallies surfaces FONR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded FONR stock?
Rallies tracks politician and congressional stock disclosures for FONR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Bonanni Luciano B bought 3.40K (~$48.14K) on Sep 30, 2022.
Damadian Timothy Raymond bought 2.20K (~$31.13K) on Sep 30, 2022.
Bonanni Luciano B bought 1.30K (~$17.97K) on Sep 29, 2022.
FONR Analyst Consensus
FONR analyst coverage data. Average price target: $0.00.
Common questions about FONR
Which politicians traded FONR stock?
Rallies tracks politician and congressional stock disclosures for FONR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in FONR?
Yes. Rallies tracks politician and congressional stock disclosures for FONR, including reported purchases, sales, dates, owners, and trade amounts when available.
Is FONR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FONR. It does not provide personalized investment advice.
